Christopher R. Loose

Christopher R. Loose

Former Chief Scientific OfficeratKorro Bio· In proxies 2022–2023

Pay in FY2023+4% from the year before · Korro Bio stock -75.1% the same year

Christopher R. Loose was paid $1.6M in FY2023 (Dec), up 4%. Korro Bio stock fell 75.1% that year.

Pay$100 in the stock at the end of FY21 → $19
Pay is from the Summary Compensation Table of each Korro Bio proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Korro BioPublic company · 4 yr
    • Former Chief Scientific Officer2022 – Present · 4 yrStock in role -95%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?